Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06502990 |
| Consolidated Lead Sponsor | Amryt Pharma |
| Therapeutic Condition Cohort | Endocrinology, Obesity, and Metabolic |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 1 participants (ACTUAL) |
| Registered Start Date | 2025-05-23 |
| WhyStopped Classification | Unspecified |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| UZ Leuven | Leuven, Belgium | Open Hospital Dossier -> |
| Universitätsklinikum Hamburg-Eppendorf | Hamburg, Germany | Open Hospital Dossier -> |
| Azienda Ospedaliera Universitaria Federico II | Naples, Italy | Open Hospital Dossier -> |
| Azienda Ospedaliero Universitaria di Parma | Parma, Italy | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.